All men with suspected prostate cancer should be offered a specialist MRI scan when they’re referred to the hospital in England, before a biopsy. And it’s a decision that prostate cancer expert Professor Mark Emberton is extremely happy about. Read the original article at: https://scienceblog.cancerresearchuk.org/2019/05/09/prostate-cancer-mri-scans-is-the-nhs-ready/...
News digest – NHS staff shortages, HPV vaccine in Rwanda, prostate cancer guidelines and sunscreen chemicals
Read about this week News Digest’s cancer research breakthrough headlines including National screening programs, a new drug for aggressive childhood brain cancer, HPV vaccination in Rwanda, and more. Original article at: https://scienceblog.cancerresearchuk.org/2019/05/11/news-digest-nhs-staff-shortages-hpv-vaccine-in-rwanda-prostate-cancer-guidelines-and-sunscreen-chemicals/...
Cancer Research UK to test targeted drug in pancreatic cancer
A dual kinase inhibitor* is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine as part of Cancer Research UK’s Combinations Alliance. The novel combination of drugs targets the process of nerve invasion, observed in over 80% of pancreatic ductal adenocarcinoma (PDAC) and is associated with tumour spread and…...
Cancer drug approved for NHS use in England gives some multiple myeloma patients another option
A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment. They say the decision will benefit approximately 2,100 patients a year. Read more at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2019-05-17-cancer-drug-approved-for-nhs-use-in-england-gives-some-multiple-myeloma-patients-another-option...
AFCR-Supported Scientist Discovers Critical Molecular Interaction, Opens New Avenue for Cancer Drug Development
(Hong Kong, April 13, 2015) Prof. Mingjie Zhang of Hong Kong University of Science and Technology, a scientist supported by the Asian Fund for Cancer Research (AFCR), recently discovered a critical molecular interaction governing epithelial cell polarity – a crucial factor in tumor formation. The research, which was funded in…...
- 1
- 2
